Form 4: KORU Medical Systems Director Shahriar Matin Reports Transaction

Director Shahriar Matin reports acquisition of 5,454 shares of KORU Medical Systems at $2.75 per share on October 1, 2024.

Summary

• On October 1, 2024, Shahriar Matin, a director of KORU Medical Systems, acquired 5,454 shares of common stock.
• The shares were purchased at a price of $2.75 per share.
• Following the transaction, Matin directly owns 73,608 shares of KORU Medical Systems.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction by a company director. It doesn't inherently indicate positive or negative sentiment, but the purchase could be interpreted as a slightly positive signal.

Positives

• A director's purchase of shares could be seen as a positive signal about the company's prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates